Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:15R-PGE1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
  logo